Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumorsBiomedicine and Pharmacotherapy, 2025, v.192, 118579
Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanomaMolecular Cancer, 2024, v.23 no.1, 45
[학술지논문] Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?IMMUNE NETWORK, 2025, v.25 no.1, 1-20
SCIE
[학술지논문] Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumorsBIOMEDICINE & PHARMACOTHERAPY, 2025, v.192 no.118579, 118579-118579
SCIE
[학술지논문] Metabolic reprogramming of the tumor microenvironment to enhance immunotherapyBMB REPORTS, 2024, v.57 no.9, 388-399
SCIE
[학술지논문] Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanomaMOLECULAR CANCER, 2024, v.23 no.1, 45-45
SCIE
[학술지논문] CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
NATURE IMMUNOLOGY, 2023, v.24 no.10, 1735-+
SCIE
[학술지논문] SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunityNATURE, 2023, v.620 no.7972, 200-+
SCIE
[학술지논문] PTEN directs developmental and metabolic signaling for innate-like T cell fate and tissue homeostasisNATURE CELL BIOLOGY, 2022, v.24 no.11, 1642-+
SCI
[학술발표] Key metabolic regulator of CD8 T cell differentiation in the tumor microenvironmentKAI UpDATE 2024, 대한민국, 2024-08-20KAI UpDATE 2024, 2024